Text Size

Quality of Life in Patients With Nonmelanoma Skin Cancer

This study has been completed.
Sponsor:
Information provided by:
Northwestern University
ClinicalTrials.gov Identifier:
NCT00518037
First received: August 15, 2007
Last updated: May 3, 2011
Last verified: May 2011
History of Changes
  Purpose

The goal of this study is to learn more about the physical discomfort, sensory impairment, depression, anxiety, and interference with relationships, family, and work associated with NMSC via survey questions.


Condition Intervention
Nonmelanoma Skin Cancer
 Behavioral: surveys

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quality of Life in Patients With Nonmelanoma Skin Cancer

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • statistics from results of Skindex survey [ Time Frame: 1 hour to complete survey ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • statistics from time-tradeoff utility survey [ Time Frame: 1 hour to complete survey ] [ Designated as safety issue: No ]

Enrollment: 112
Study Start Date: June 2006
Study Completion Date: October 2006
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
nonmelanoma skin cancer patients
 Behavioral: surveys
anxiety surveys

Detailed Description:

The purpose of this study is to learn more about the physical discomfort, sensory impairment, depression, anxiety, and interference with relationships, family, and work associated with NMSC via survey questions.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

nonmelanoma skin cancer patients

Criteria

Inclusion Criteria:

  • patients with nonmelanoma skin cancer
  • 18 years of age

Exclusion Criteria:

  • non-English speakers
  • minors
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00518037

Locations
United States, Illinois
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
Northwestern University Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Investigators
Principal Investigator: Murad Alam, MD Northwestern University
  More Information

No publications provided

Responsible Party: Murad Alam, MD, Northwestern University
ClinicalTrials.gov Identifier: NCT00518037     History of Changes
Other Study ID Numbers: 1253-006
Study First Received: August 15, 2007
Last Updated: May 3, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Skin Neoplasms
Carcinoma, Basal Cell
Carcinoma, Basosquamous
Carcinoma, Squamous Cell
Neoplasms by Site
Neoplasms
 Skin Diseases
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Basal Cell
Neoplasms, Squamous Cell

ClinicalTrials.gov processed this record on May 21, 2013